Cargando…

Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy

This study aimed to determine the optimal fraction scheme (FS) in patients with small peripheral non-small cell lung cancer (NSCLC) undergoing stereotactic body radiotherapy (SBRT) with the 4 × 12 Gy scheme as the reference. CT simulation data for sixteen patients diagnosed with primary NSCLC or met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Bao-Tian, Lu, Jia-Yang, Lin, Pei-Xian, Chen, Jian-Zhou, Li, De-Rui, Chen, Chuang-Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676016/ https://www.ncbi.nlm.nih.gov/pubmed/26657569 http://dx.doi.org/10.1038/srep18010

Ejemplares similares

Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer
por: Huang, Bao-tian, et al.
Publicado: (2016)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Radiobiology of stereotactic radiotherapy
por: Mangoni, Monica, et al.
Publicado: (2022)

Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer
por: Lu, Jia-Yang, et al.
Publicado: (2019)

Monitor unit optimization in stereotactic body radiotherapy for small peripheral non-small cell lung cancer patients
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

Radiobiological Optimization in Lung Stereotactic Body Radiation Therapy: Are We Ready to Apply Radiobiological Models?
por: D’Andrea, Marco, et al.
Publicado: (2018)

Comparison of Two RapidArc Delivery Strategies in Stereotactic Body Radiotherapy of Peripheral Lung Cancer with Flattening Filter Free Beams
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

Radiobiology of stereotactic ablative radiotherapy (SABR): perspectives of clinical oncologists
por: Li, Shan, et al.
Publicado: (2020)

Radiobiological and Treatment-Related Aspects of Spatially Fractionated Radiotherapy
por: Moghaddasi, Leyla, et al.
Publicado: (2022)

Radiobiological Aspects of FLASH Radiotherapy
por: Hageman, Eline, et al.
Publicado: (2022)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer
por: Dai, Zhi-tao, et al.
Publicado: (2021)

Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy
por: Xue, Hui, et al.
Publicado: (2021)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
por: Zarębska, Izabela, et al.
Publicado: (2023)

CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations
por: Conti, Alfredo, et al.
Publicado: (2015)

Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans
por: Liang, X., et al.
Publicado: (2016)

Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function
por: Lu, Jia-Yang, et al.
Publicado: (2019)

Optimized workflow to minimise intra-fractional motion during stereotactic body radiotherapy of spinal metastases
por: vanNiekerk, W.M., et al.
Publicado: (2022)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
por: Kalinauskaite, Goda G., et al.
Publicado: (2020)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Stereotactic body proton therapy for liver tumors: Dosimetric advantages and their radiobiological and clinical implications
por: Arscott, W. Tristram, et al.
Publicado: (2018)

The Radiobiology of Human Cancer Radiotherapy
por: Hendry, J. H., et al.
Publicado: (1979)

Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations
por: Herman, Tania De La Fuente, et al.
Publicado: (2010)

Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022)

From Basic Radiobiology to Translational Radiotherapy
por: Chailapakul, Piyawan, et al.
Publicado: (2022)

Comparative Analysis of Local Control Prediction Using Different Biophysical Models for Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy
por: Huang, Bao-Tian, et al.
Publicado: (2017)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

A Combined Model to Improve the Prediction of Local Control for Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy Based on Radiomic Signature Plus Clinical and Dosimetric Parameters
por: Luo, Li-Mei, et al.
Publicado: (2022)

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
por: Elhateer, H., et al.
Publicado: (2008)

Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma
por: Higgins, Patrick D., et al.
Publicado: (2006)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2017)

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma
por: Liu, Feng, et al.
Publicado: (2013)

Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report
por: Nonaka, Hotaka, et al.
Publicado: (2017)

Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer
por: Huang, Bao-Tian, et al.
Publicado: (2017)

Radiobiological Framework for the Evaluation of Stereotactic Radiosurgery Plans for Invasive Brain Tumours
por: Sandström, Helena, et al.
Publicado: (2013)

A radiobiological study of the schemes with a low number of fractions in high-dose-rate brachytherapy as monotherapy for prostate cancer
por: Guirado, Damián, et al.
Publicado: (2020)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
por: Wang, Shih-Chang, et al.
Publicado: (2020)

Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
por: P. Weiner, Joseph, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_356qfd19h05ikb45kterl7j73p